🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 13 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2024 28,28 28,36 27,21 28,14 -0,50% 4,07% 1.273.900
15/03/2024 27,16 29,01 27,00 28,28 +3,14% 7,40% 3.735.900
14/03/2024 28,16 28,30 27,01 27,42 -4,09% 4,58% 1.621.700
13/03/2024 28,51 29,15 28,19 28,59 +0,14% 3,37% 1.484.700
12/03/2024 29,23 29,43 28,26 28,55 -2,89% 4,00% 1.423.100
11/03/2024 33,01 33,02 29,26 29,40 -12,11% 11,39% 2.298.200
08/03/2024 33,58 35,47 33,38 33,45 +0,75% 6,22% 1.019.500
07/03/2024 35,63 35,80 33,14 33,20 -6,21% 7,48% 1.105.200
06/03/2024 34,80 35,66 34,12 35,40 +3,87% 4,43% 1.627.800
05/03/2024 34,73 35,72 33,74 34,08 -2,93% 5,70% 867.300
04/03/2024 36,60 36,72 34,73 35,11 -2,69% 5,44% 1.237.100
01/03/2024 32,36 36,24 32,30 36,08 +12,40% 12,18% 2.242.400
29/02/2024 34,50 35,36 31,83 32,10 -5,59% 10,23% 2.715.400
28/02/2024 30,98 34,79 30,87 34,00 +9,10% 12,65% 5.053.500
27/02/2024 30,60 31,21 29,46 31,17 +2,21% 5,74% 2.039.100
26/02/2024 31,84 32,48 30,29 30,49 -3,50% 6,88% 1.521.200
23/02/2024 30,25 31,90 30,04 31,60 +4,62% 6,15% 2.520.500
22/02/2024 29,27 30,84 28,50 30,20 +3,50% 7,99% 1.211.500
21/02/2024 29,22 29,62 28,94 29,18 -0,14% 2,34% 860.300
20/02/2024 29,05 29,56 28,71 29,22 -0,88% 2,93% 1.012.200
16/02/2024 29,13 30,12 28,53 29,48 -0,30% 5,46% 1.071.300
15/02/2024 29,77 30,39 29,46 29,57 -0,20% 3,12% 1.237.200
14/02/2024 30,28 30,50 29,30 29,63 -0,97% 3,96% 1.035.200
13/02/2024 31,23 31,23 29,41 29,92 -7,25% 5,83% 1.805.200
12/02/2024 32,56 33,02 31,47 32,26 -0,92% 4,76% 1.247.100
09/02/2024 30,93 32,68 30,62 32,56 +5,54% 6,64% 1.459.800
08/02/2024 31,93 32,57 30,76 30,85 -2,53% 5,67% 1.764.100
07/02/2024 31,75 31,92 29,50 31,65 -4,67% 7,62% 3.220.100
06/02/2024 31,93 33,30 31,50 33,20 +3,69% 5,64% 1.092.600
05/02/2024 31,23 32,47 30,54 32,02 +0,19% 6,18% 971.800